Review Article | OPEN ACCESS DOI: 10.23937/2378-346X/1410153

A Comprehensive Overview of an Association between Vogt-Koyanagi-Harada Illness and Bechet's Disease

Sagnika Bhattacharjee*, Sakshi Gupta, Supta Chakraborty, Madhvi Ghadge, Pallavi and Vartika Jain

School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India

Abstract

The uvea, comprising the blood vessels in the choroid retina, ciliary body, and iris, experiences inflammation. Non-infectious conditions, such as Vogt-Koyanagi-Harada illness and Bechet's disease, frequently cause uveitis. However, the pathophysiology of uveitis is also idiopathic. Unbalanced immune systems, genetics, and epigenetics all have a pivotal role in the development of disease. Several racial and ethnic groups strongly link HLA to BD (HLA-B51) and VKH (Vogt-Koyanagi-Harada) (HLA-DR4, DRB/DQA1). A study into the pathophysiology of uveitis claims a link between SUMO4, MCP-1, and CTLA4. A genome-wide association study (GWAS) showed that the genes IL23R/C1orf141, STAT4, and ADO/ZNF365/EGR2 all play a part in the development of uveitis. IL17F, IL23A, and C4A are examples of copy number variations (CNV) linked to uveitis. Additionally, epigenetic factors like DNA methylation and ncRNAs have a big impact on how the disease manifests itself. Exome, genome, and other epigenetic alterations may assist in identifying novel uveitis pathogenesis risk genes. Therefore, a deeper understanding of the condition's genetics could potentially improve uveitis management.

Keywords

Uveitis, Vogt-Koyanagi-Harada, Behcet’s disease, Genetic predisposition, Single Nucleotide Polymorphisms (SNPs)

Introduction

Uveitis is defined as inflammation of the uvea, which includes the iris, ciliary body, choroid, retina, and associated blood vessels [1]. We classify this condition as an intraocular inflammatory illness [2]. In uveitis, Behcet’s disease (BD) and Vogt-Koyanagi-Harada disease (VKH) are common non-infectious causes [3]. Both BD Behcet's disease (BD) and Vogt-Koyanagi-Harada disease (VKH) are autoinflammatory diseases. BD has recurrent oral aphthae, skin lesions, genital ulcers, and non-granulomatous uveitis. On the other hand, VKH has poliosis, vitiligo, alopecia, hearing problems, and granulomatous panuveitis on both sides and CNS abnormality [4-6]. The pathogenesis of uveitis is undetermined. People with more melanin, such as Asians and Native Americans, are prone to VKH disease, while BD, also known as Silk Road Disease, is prevalent in China, Japan, Korea, and Turkey [7,8]. A previous study demonstrates that human leukocyte antigens (HLA) in various racial groups closely correlate with the transmission of VKH sickness and Bechet's disease through families [9]. Researchers also found extreme variation in the clinical symptoms and onset ages of monozygotic twins with uveitis [10]. Integrating the data shows that epigenetic changes in association with an aberrant immune response are the primary causes of complicated genetic conditions or uveitis. Considering the fact that BD and VKH are both immune-mediated illnesses, the initial study primarily investigated the correlation with HLA polymorphism. HLA is largely located on the short arm of chromosome 6, which has a length of around 4 × 10 -6 bp and contains several genes encoding proteins that also play a crucial and essential role in HLA. We can categorise HLA into three classes: class I, class II, and class II genes, based on the structure, tissue distribution, and functional variations of its coding molecules [11]. HLA-B51 is known to be a significant risk factor for BD across different ethnicities [12]. Researchers have found a significant link between HLA-DR4, DRB1/DQA1, and VKH disease among various ethnic groups [13]. Despite the substantial link between HLA, Bechet's illness and VKH disease, researchers estimated that HLA only accounts for 19% of the total genetic susceptibility to both diseases. Many studies then looked at the correlation between the above-described parameters and non-HLA genes. With VKH sickness and Behcet's disease. This review covers the most recent findings about the relationship between non-HLA genetic or epigenetic variables and the diseases BD and VKH.

The Genetic Investigation into BD and VKH Disease is Ongoing

Single-site variations, like single nucleotide polymorphisms (SNPs), and structural variants, like copy number variations (CNVs), are two categories of genetic variants. Variants vary from minor base changes to significant fragment mutations [14].

The Genetic Role of CNVs in VKH Disease and BD

SNPs make up less than 1% of the human genome, while big DNA sequence variations, also known as copy nerve variations, make up between 5 and 10% of the genome. These variations encode different copies of a particular gene. These CNVs can account for around 10-20% of the heritability of specific diseases since their mutation rate is substantially higher than that of SNPs.

Although the cause of their aberrant expression is unclear, previous investigations have indicated that patients with uveitis express a variety of inflammatory factors dysfunctionally. We looked at the link between copy number variations (CNVs) in IL17F, IL23A, and C4A and BD and VKH disease to learn more about their genetic basis. Outcomes are depicted in Figure. Refer to Figure 1 [15].

Figure 1: This picture shows the results, which showed a link between higher levels of IL17F, IL23A, and C4A expression and high copy numbers of IL17F, IL23A, and C4A in people with Bechet's illness or VKH disease. This suggests that these CNVs play a part in the development of uveitis. View Figure 1

The Association of SNP with VKH and BD is Significant

Single nucleotide polymorphisms or SNPs are the most common and abundant form of genetic variation in humans. We evaluate more than 3 million SNPs in the human genome. Sequence variations of the genome spawned by single nucleotide base pair alternatives generate sequence variations in the genome. 90% of phenotypic variations are due to SNPs. The human chromosome 2q33 of the CD28 gene family has a cytotoxic T-lymphocyte-associated antigen (CTLA-4). The latest studies demonstrate the relationship between CTLA4 gene polymorphisms (-1661A/G, -318C/T, +49G/A, and CT60) and BD and VKH diseases in the Chinese Han population [16,17]. VKH aligned with haplotypes 1661A, 318C, +49G, CT60G, and +49G, but did not align with BD. Therefore, VKH and BD show genetic heterogeneity. Clinical presentations of both diseases vary; BD is non-granulomatous inflammation, whereas VKH is granulomatous inflammation [18]. The preceding data depicts the association between CTLA4 gene polymorphism and BD in different ethnic cohorts. Small ubiquitin-like modifier 4 (SUMO4) is found on chromosome 6p25. SUMO4 controls the transcription of nuclear factor kappa B (NF-kB). SUMO4 is involved in a plethora of autoimmune diseases, such as type 1 diabetes [19]. Vascular-related diseases like diabetic neuropathy and diabetes mellitus associated uveitis (DMAU) typically complicate diabetes [20]. In the Chinese Han population, association of the SUMO4 +438 C allele and AGAT haplotype with BD was ruled out [21]. Investigations performed by Korean and Tunisian groups substantiate the analysis [22]. SUMO 4 happens to be an unsafe gene for vascular autoimmune diseases like BD and Type 1 diabetes. A genome-wide association study (GWAS) is a fair and dynamic tool for determining any genetic variant associated with human diseases. We conducted GWAS on Bechet's patients in Turkey. We ruled out five related genes, including KIAA1529, CPVL, LOC100129342, UBASH3B, and UBAC2. Further investigations revealed that UBAC2, among the five mentioned genes, was associated with BD in Chinese Han, Italian, and Japanese populations. Therefore, UBAC2 may be a common hazardous gene for various ethnic populations. Furthermore, researchers examined genetic predispositions related to VKH and BD in Chinese Han individuals. We observe a close relationship between BD and STAT4. The presence of SNP rs897200 in STAT4 affects the binding of STAT4 with transcription factors like YY1 and POUIF1a, as demonstrated by bioinformatics and functional studies. We observe an intensification of STAT4's transcriptional potential, which further triggers the release of proinflammatory factors like IL-17, clearly demonstrating STAT4's involvement in BD through Th17 pathway regulation. Researchers found a significant association between BD and STAT4 in Korean and Turkish groups [23]. GWAS analysis perforate large sample population's GWAS analysis revealed VKH's association with numerous non-HLA genes, including IL23R/C1orf141 and AD study was conducted in Singaporean, Thai, and Korean populations to rule out the relationship between VKH and the IL23R/C1orf141, EGR2/ADO, and ZNF365 genes. IL23R/C1orf141 is associated with Singaporean VKH patients [13], whereas EGR2/ZNF365/ADO is associated with VKH in the Thai population. An intriguing aspect of the study was the association of EGR2/ADO with BD in Chinese Han and Turkish ethnic groups [24].

Epigenetic Studies on VKH and BD

'Epigenetics' is the term for the branch of genetics that does not include DNA sequencing. It focuses on factors such as DNA methylation, histone modification, and non-coding RNA (ncRNA) that may alter gene expression. The process of DNA methylation involves the precise covalent attachment of methyl groups to DNA bases and the cytosine of CpG dinucleotides. In the case of Bechet's, recent studies explain DNA methylation in monocytes and CD4+ T cells. Researchers evaluated 383 differentially methylated CpG sites in monocytes and 125 differentially methylated CpG sites in CD4+ T cells in patients with BD [25]. Another DNA methylation study suggests a link between 4332 differentially methylated CpG and BD. A replication study suggests an association between BD at 5’UTR and FKBP5 [26]. There is a high prevalence of GATA3, IL-4, and TGF-beta in patients with VKH disease [27]. Therefore, DNA methylation plays a role in the development of both BD and VKH. Types of ncRNA are ncRNA, miRNA, and circRNA, classified based on their sequence length. BD results in a decrease in miR-155 expression, while VKH strongly associates with variations in the copy number of miR-23a, miR-146a, and miR-301a [28]. ProinflammaThe overexpression of miR-23a in ARPE-19 cells activates proinflammatory cytokines, sucThus, research has proven that ncRNAs play a vital role in a normal immune response that leads to BD and VKH [29].

Conclusion

A variety of clinical symptoms, commonly including extraocular and ocular sites, characterize uveitis, a complex multisystem disease. This study examines VKH and BD, the two most significant genetic risk factors for uveitis. Although uveitis has an idiopathic etiopathogenesis, Evidence suggests that a combination of certain genetic or epigenetic factors may be responsible for an imbalance in immune response regulation, leading to the development of uveitis. Researchers have drawn an association between VKH and BD with specific HLA types, numerous SNPs or CNVs in non-HLA genes, ncRNAs, and DNA methylation in various ethnic communities. A tiny fraction of identified genes accounts for genetic uveitis, and we will soon discover many more genes responsible for the condition. The application of various modern technologies, such as whole genome sequencing and whole exome sequencing, as well as the analysis of certain other epigenetic factors, such as N6 methyl adenosine modification of mRNAs, will be helpful in the identification of new pathogenic risk genes for uveitis. Understanding the genetic and epigenetic mechanisms of uveitis may assist in developing a foundation for the discovery of new targets and may lead to the development of novel strategies in the treatment of uveitis in the coming future.

Declarations

Ethics approval and consent to participate

Not applicable.

Conflict of interest

Authors have no conflicts of interest to declare.

Consent for publication

Not applicable.

Competing interests

Not applicable.

Funding

Not applicable.

Acknowledgement

I extend my heartiest gratitude towards my parents, a special thanks to our guide Madhvi Ghadhge Ma’am, Vartika Jain, Pallavi and all other co-authors for immense support throughout the article.

Authors' contribution

SB(Sagnika Bhattacharjee), SG(Sakshi Gupta), SC(Supta Chakraborty), MG(Madhvi Ghadhge), Pallavi, Dr VJ (Vartika. Jain) have equally contributed to the article, SB(Sagnika Bhattacharjee) analyzed previous article, reviewed them, prepared the discussion and conclusion section and contributed in overall refining of the manuscript, SC(Supta Chakraborty) has prepared the images, SG(Sakshi Gupta has written some portion of manuscript ), Dr. Vartika Jain (VJ), Madhvi Ghadhge (MG), Pallavi has assisted and guided in preparing the manuscript.

All the authors have equally contributed. The authors have read and approved the final manuscript.

References

  1. Khanamiri HN, Rao NA (2013) Serpiginous choroiditis and infectious multifocal serpiginous choroiditis. Surv Ophthalmol 58: 203-232.
  2. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, et al. (1992) Uveitis and systemic disease. Br J Ophthalmol 76: 137-141.
  3. Yang P, Zhang Z, Zhou H, Li B, Huang X, et al. (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30: 943-948.
  4. Yang P, Liu S, Zhong Z, Du L, Ye Z, et al. (2019) Comparison of clinical features and visual outcome between sympathetic ophthalmia and Vogt-Koyanagi-Harada disease in Chinese patients. Ophthalmol 126: 1297-1305.
  5. Yang P, Ren Y, Li B, Fang W, Meng Q, et al. (2007) Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmol 114: 606-614.
  6. Gul A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4: 81-83.
  7. Gül A, Inanç M, Öcal L, Aral O, Koniçe M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59: 622-625.
  8. Berman LO, Trappler BR, Jenkins TR (1979) Behçet's syndrome: a family study and the elucidation of a genetic role. Ann Rheum Dis 38: 118-1121.
  9. Weisz JM, Holland GN, Roer LN, Park MS, Yuge AJ, et al. (1995) Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and-DR4 in Hispanic patients living in southern California. Ophthalmology 102: 1012-1015.
  10. Rutzen AR, Ortega-Larrocea G, Schwab IR, Rao NA (1995) Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 119: 239-240.
  11. Ono S, Nakayama E, Sugiura S, Itakura K, Aoki K (1975) Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol 80: 636-641.
  12. Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, et al. (2013) Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B* 51 and ERAP1. Nat Genet 45: 202-207.
  13. Hou S, Du L, Lei B, Pang CP, Zhang M, et al. (2014) Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31. 2 and 10q21. 3. Nat Genet 46: 1007-1011.
  14. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST (2011) American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 13: 680-685.
  15. Hou S, Liao D, Zhang J, Fang J, Chen L, et al. (2015) Genetic variations of IL17F and IL23A show associations with Behcet’s disease and Vogt-Koyanagi-Harada syndrome. Ophthalmology 122: 518-523.
  16. Du L, Yang P, Hou S, Lin X, Zhou H, et al. (2008) Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol 127: 43-48.
  17. Du L, Yang P, Hou S, Zhou H, Kijlstra A (2009) No association of CTLA-4 polymorphisms with susceptibility to Behçet disease. Br J Ophthalmol 93: 1378-1381.
  18. Inomata H, Minei M, Taniguchi Y, Nishimura F (1983) Choroidal neovascularization in long-standing case of Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 27: 9-26.
  19. Tsurumaru M, Kawasaki E, Ida H, Migita K, Moriuchi A, et al. (2006) Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. J Clin Endocrinol Metab 91: 3138-3143.
  20. Sabat PE, Anguita R, Saez V, Morales S, Urzúa CA, et al. (2020) Diabetes mellitus-associated uveitis: Clinical Features in a chilean series. Ocul Immunol Inflamm 28: 571-574.
  21. Hou S, Yang P, Du L, Zhou H, Lin X, et al. (2008) SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 129: 170-175.
  22. Karray EF, Bendhifallah I, Zakraoui L, Hamzaoui K (2011) Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Clin Exp Rheumatol 29: 751.
  23. Park G, Kim HS, Choe JY, Kim SK (2012) SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet’s disease. Rheumatol Int 32: 3031-3037.
  24. Cao S, Chee SP, Yu HG, Sukavatcharin S, Wu L, et al. (2016) Investigation of the association of Vogt-Koyanagi-Harada syndrome with IL23R-C1orf141 in Han Chinese Singaporean and ADO-ZNF365-EGR2 in Thai. Br J Ophthalmol 100: 436-442.
  25. Hamzaoui K, Hamzaoui A (2023) Interleukin-1 family in Behçet’s disease: Inflammatory and antiinflammatory mediators. Translational Autoimmunity 6: 487-507.
  26. Hughes T, Ture-Ozdemir F, Alibaz-Oner F, Coit P, Direskeneli H, et al. (2014) Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behcet's disease. Arthritis Rheumatol 66: 1648-1658.
  27. Yu H, Du L, Yi S, Wang Q, Zhu Y, et al. (2019) Epigenome-wide association study identifies Behcet’s disease-associated methylation loci in Han Chinese. Rheumatology 58: 1574-1584.
  28. Zhu Y, Yu H, Qiu Y, Ye Z, Su W, et al. (2017) Promoter hypermethylation of GATA3, IL-4, and TGF-β confers susceptibility to Vogt-Koyanagi-Harada disease in Han Chinese. Invest Ophthalmol Vis Sci 58: 1529-1536.
  29. Hou S, Ye Z, Liao D, Bai L, Liu Y, et al. (2016) miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet’s disease. Sci Rep 6: 20057.

Citation

Bhattacharjee S, Gupta S, Chakraborty S, Ghadge M, Pallavi, et al. (2024) A Comprehensive Overview of an Association between Vogt-Koyanagi-Harada Illness and Bechet's Disease. Int J Ophthalmol Clin Res 11:153. doi.org/10.23937/2378-346X/1410153